Decline of disease activity and autoantibodies to desmoglein 3 and envoplakin by oral prednisolone in paraneoplastic pemphigus with benign thymoma

Eur J Dermatol. 2012 Jul-Aug;22(4):547-9. doi: 10.1684/ejd.2012.1742.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Administration, Oral
  • Aged
  • Autoantibodies* / analysis
  • Desmoglein 3 / immunology*
  • Female
  • Glucocorticoids / administration & dosage*
  • Humans
  • Membrane Proteins / immunology*
  • Paraneoplastic Syndromes / immunology*
  • Pemphigus / complications
  • Pemphigus / drug therapy*
  • Pemphigus / immunology*
  • Prednisolone / administration & dosage*
  • Protein Precursors / immunology*
  • Thymoma / complications
  • Thymoma / immunology*
  • Thymus Neoplasms / complications
  • Thymus Neoplasms / immunology*

Substances

  • Autoantibodies
  • Desmoglein 3
  • Glucocorticoids
  • Membrane Proteins
  • Protein Precursors
  • envoplakin
  • Prednisolone